Compassionate use of oral beclomethasone dipropionate [beclometasone] for treatment of gastrointestinal graft versus host disease.
Phase of Trial: Phase II
Latest Information Update: 07 Mar 2011
At a glance
- Drugs Beclometasone (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 24 Sep 2010 Actual end date (Apr 2006) added as reported by ClinicalTrials.gov.
- 24 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Jun 2008 DOR Biopharma has withdrawn centralised MAA application from EMEA.